These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24635751)

  • 1. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
    Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
    Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas.
    Samaniego F; Hagemeister F; Romaguera JE; Fanale MA; Pro B; McLaughlin P; Rodriguez MA; Neelapu SS; Fayad L; Younes A; Feng L; Berkova Z; Khashab T; Sehgal L; Vega-Vasquez F; Kwak LW
    Br J Haematol; 2015 Jun; 169(6):814-23. PubMed ID: 25828695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).
    Martínez-Banaclocha N; Martínez-Madueño F; Caballé B; Badia J; Blanes M; Bujanda DA; Calvo V; Gómez Codina J; Blanco CQ; Espinosa P; Lavernia J; Arroyo FRG; Risueño MG; Llorca C; Cumeras R; Pulla MP; Gumà J
    Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retreatment with chimeric CD 20 monoclonal antibody in a patient with nodal marginal zone B-cell lymphoma.
    Koh LP; Lim LC; Thng CH
    Med Oncol; 2000 Aug; 17(3):225-8. PubMed ID: 10962535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated liposomal doxorubicin combined with cyclophosphamide and vincristine in pediatric patients with relapsed/refractory solid tumor: a single-arm, open-label, phase I study.
    Lu S; Wang J; Huang J; Sun F; Zhu J; Que Y; Li H; Guo Y; Cai R; Zhen Z; Sun X; Zhang Y
    EClinicalMedicine; 2024 Jul; 73():102701. PubMed ID: 39007065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous B-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.
    Hristov AC; Tejasvi T; Wilcox RA
    Am J Hematol; 2020 Oct; 95(10):1209-1213. PubMed ID: 32815650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results.
    Xia ZG; Lv FF; Zhang QL; Liu YZ; Zhang SJ; Liu C; Li XQ; Wen Y; Wu ZY; Hong XN; Guo Y; Cao JN
    Oncologist; 2024 May; ():. PubMed ID: 38821519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
    Picardi M; Giordano C; Pugliese N; Mascolo M; Varricchio S; Troncone G; Vigliar E; Bellavicine C; Lamagna M; Lisi D; Vincenzi A; Pane F
    Hematol Oncol; 2024 Jan; 42(1):e3247. PubMed ID: 38287530
    [No Abstract]   [Full Text] [Related]  

  • 9. Weekly pegylated liposomal doxorubicin and paclitaxel in patients with metastatic breast carcinoma: A phase II study.
    Leonardi V; Palmisano V; Pepe A; Usset A; Manuguerra G; Savio G; DE Bella MT; Laudani A; Alù M; Cusimano MP; Scianna C; Giresi A; Agostara B
    Oncol Lett; 2010 Jul; 1(4):749-753. PubMed ID: 22966374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.
    Braunstein Z; Waller A; Dotson E; McLaughlin E; Hanel W; Reneau J; Addison D; Porcu P; Brammer JE
    Leuk Lymphoma; 2024 Mar; 65(3):301-311. PubMed ID: 38093530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma.
    D'Angelo SP; Munhoz RR; Kuk D; Landa J; Hartley EW; Bonafede M; Dickson MA; Gounder M; Keohan ML; Crago AM; Antonescu CR; Tap WD
    Oncology; 2015; 89(4):205-14. PubMed ID: 26043723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous marginal zone lymphoma presenting with secondary chilblains of the toes.
    Nasir AZ; Burmeister RS
    BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37640411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual case of B-cell lymphoma of the scalp.
    Chaudhry N; Qureshi A; Gollamudi S; Kasbawala K; Clopton BJ; Moore C; Genato R; Xiao P; Asarian A
    J Surg Case Rep; 2023 Nov; 2023(11):rjad639. PubMed ID: 38045789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
    Picardi M; Giordano C; Pugliese N; Mascolo M; Varricchio S; Troncone G; Vigliar E; Bellavicine C; Lamagna M; Lisi D; Vincenzi A; Pane F
    Hematol Oncol; 2024 Jan; 42(1):e3242. PubMed ID: 38126215
    [No Abstract]   [Full Text] [Related]  

  • 15. Adolescent with primary cutaneous follicle center lymphoma treated with rituximab.
    Devine KJ; Freiberg AS; Reilly AF
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30885. PubMed ID: 38253812
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole-associated QTc prolongation in a geriatric patient.
    Hategan A; Bourgeois JA
    J Clin Psychopharmacol; 2014 Dec; 34(6):766-8. PubMed ID: 25203469
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study evaluating efficacy and safety of everolimus with letrozole for management of advanced (unresectable or metastatic) non-small cell lung cancer after failure of platinum-based treatment: a preliminary analysis of toxicity.
    Singhal N; Vatandoust S; Brown MP
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):325-31. PubMed ID: 25502181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02.
    Rivera F; Massutí B; Salcedo M; Sastre J; Martínez Galán J; Valladares-Ayerbes M; Serrano R; García de Paredes ML; Manzano JL; Galán M; Alsina M; Yuste Izquierdo AL; López C; Díaz-Rubio E; Conde V; Reboredo M; Cano MT; Pachón V; Aranda E
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):319-24. PubMed ID: 25491381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib in ABO-incompatible kidney transplant desensitization: a case report.
    Wong NL; O'Connell P; Chapman JR; Nankivell B; Kable K; Webster AC; Wong G
    Nephrology (Carlton); 2015 Mar; 20 Suppl 1():22-4. PubMed ID: 25807854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Painful legs and moving toes syndrome responsive to pregabalin.
    Rossi FH; Liu W; Geigel E; Castaneda S; Rossi EM; Schnacky K
    J Postgrad Med; 2015; 61(2):116-9. PubMed ID: 25766346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.